| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |